143 related articles for article (PubMed ID: 21786339)
21. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
22. The antigenotoxic effects of grapefruit juice on the damage induced by benzo(a)pyrene and evaluation of its interaction with hepatic and intestinal Cytochrome P450 (Cyp) 1a1.
Alvarez-Gonzalez I; Mojica R; Madrigal-Bujaidar E; Camacho-Carranza R; Escobar-García D; Espinosa-Aguirre JJ
Food Chem Toxicol; 2011 Apr; 49(4):807-11. PubMed ID: 21130824
[TBL] [Abstract][Full Text] [Related]
23. Antimutagenic activity of spearmint.
Yu TW; Xu M; Dashwood RH
Environ Mol Mutagen; 2004; 44(5):387-93. PubMed ID: 15529323
[TBL] [Abstract][Full Text] [Related]
24. Involvement of cytochrome P450 1A in sanguinarine detoxication.
Vrba J; Kosina P; Ulrichová J; Modrianský M
Toxicol Lett; 2004 Jul; 151(2):375-87. PubMed ID: 15183462
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of rat liver microsomal CYP1A2 and CYP2B1 activity by N-(2-heptyl)-N-methyl-propargylamine and by N-(2-heptyl)-propargylamine.
Dyck LE; Davis BA
Drug Metab Dispos; 2001 Aug; 29(8):1156-61. PubMed ID: 11454735
[TBL] [Abstract][Full Text] [Related]
26. Interaction of
Delgado-Roche L; Santes-Palacios R; Herrera JA; Hernández SL; Riera M; Fernández MD; Mesta F; Garrido G; Rodeiro I; Espinosa-Aguirre JJ
Mar Drugs; 2020 Nov; 18(11):. PubMed ID: 33227946
[TBL] [Abstract][Full Text] [Related]
27. Bergamottin is a competitive inhibitor of CYP1A1 and is antimutagenic in the Ames test.
Olguín-Reyes S; Camacho-Carranza R; Hernández-Ojeda S; Elinos-Baez M; Espinosa-Aguirre JJ
Food Chem Toxicol; 2012 Sep; 50(9):3094-9. PubMed ID: 22705772
[TBL] [Abstract][Full Text] [Related]
28. Lactobacillus- and bifidobacterium-mediated antigenotoxicity in the colon of rats.
Pool-Zobel BL; Neudecker C; Domizlaff I; Ji S; Schillinger U; Rumney C; Moretti M; Vilarini I; Scassellati-Sforzolini R; Rowland I
Nutr Cancer; 1996; 26(3):365-80. PubMed ID: 8910918
[TBL] [Abstract][Full Text] [Related]
29. Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes.
Yamaori S; Kushihara M; Yamamoto I; Watanabe K
Biochem Pharmacol; 2010 Jun; 79(11):1691-8. PubMed ID: 20117100
[TBL] [Abstract][Full Text] [Related]
30. Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.
Eugster HP; Probst M; Würgler FE; Sengstag C
Drug Metab Dispos; 1993; 21(1):43-9. PubMed ID: 8095225
[TBL] [Abstract][Full Text] [Related]
31. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Aug; (530):1-258. PubMed ID: 17160104
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P4501A1 mediates the metabolism of 2,3,7,8-tetrachlorodibenzofuran in the rat and human.
Tai HL; McReynolds JH; Goldstein JA; Eugster HP; Sengstag C; Alworth WL; Olson JR
Toxicol Appl Pharmacol; 1993 Nov; 123(1):34-42. PubMed ID: 8236259
[TBL] [Abstract][Full Text] [Related]
33. Subchronic dietary exposure to Aroclor 1254 in rats: accumulation of PCBs in liver, blood, and adipose tissue and its relationship to induction of various hepatic drug-metabolizing enzymes.
Dragnev KH; Beebe LE; Jones CR; Fox SD; Thomas PE; Nims RW; Lubet RA
Toxicol Appl Pharmacol; 1994 Mar; 125(1):111-22. PubMed ID: 7510429
[TBL] [Abstract][Full Text] [Related]
34. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002.
Shimada T; Iwasaki M; Martin MV; Guengerich FP
Cancer Res; 1989 Jun; 49(12):3218-28. PubMed ID: 2655891
[TBL] [Abstract][Full Text] [Related]
35. Mechanism-based inactivation of hepatic ethoxyresorufin O-dealkylation activity by naturally occurring coumarins.
Cai Y; Baer-Dubowska W; Ashwood-Smith MJ; Ceska O; Tachibana S; DiGiovanni J
Chem Res Toxicol; 1996 Jun; 9(4):729-36. PubMed ID: 8831817
[TBL] [Abstract][Full Text] [Related]
36. Activation of aminophenylnorharman, aminomethylphenylnorharman and aminophenylharman to genotoxic metabolites by human N-acetyltransferases and cytochrome P450 enzymes expressed in Salmonella typhimurium umu tester strains.
Oda Y; Totsuka Y; Wakabayashi K; Guengerich FP; Shimada T
Mutagenesis; 2006 Nov; 21(6):411-6. PubMed ID: 17067997
[TBL] [Abstract][Full Text] [Related]
37. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450.
Muto S; Fujita K; Yamazaki Y; Kamataki T
Mutat Res; 2001 Aug; 479(1-2):197-206. PubMed ID: 11470492
[TBL] [Abstract][Full Text] [Related]
38. Antimutagenic activity of flavonoids from Chrysanthemum morifolium.
Miyazawa M; Hisama M
Biosci Biotechnol Biochem; 2003 Oct; 67(10):2091-9. PubMed ID: 14586095
[TBL] [Abstract][Full Text] [Related]
39. Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamine.
Sy SK; Tang BK; Pastrakuljic A; Roberts EA; Kalow W
Eur J Clin Pharmacol; 2001 Aug; 57(5):377-86. PubMed ID: 11599655
[TBL] [Abstract][Full Text] [Related]
40. SOS-inducing activity of chemical carcinogens and mutagens in Salmonella typhimurium TA1535/pSK1002: examination with 151 chemicals.
Nakamura SI; Oda Y; Shimada T; Oki I; Sugimoto K
Mutat Res; 1987 Dec; 192(4):239-46. PubMed ID: 3317033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
